Phospholipase D activity underlies very-low-density lipoprotein (VLDL)-induced aldosterone production in adrenal glomerulosa cells.
about
The phospholipase D superfamily as therapeutic targetsPhospholipase D2 loss results in increased blood pressure via inhibition of the endothelial nitric oxide synthase pathway.VLDL-activated cell signaling pathways that stimulate adrenal cell aldosterone production.Aging and Adrenal Aldosterone Production.
P2860
Phospholipase D activity underlies very-low-density lipoprotein (VLDL)-induced aldosterone production in adrenal glomerulosa cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Phospholipase D activity under ...... in adrenal glomerulosa cells.
@en
type
label
Phospholipase D activity under ...... in adrenal glomerulosa cells.
@en
prefLabel
Phospholipase D activity under ...... in adrenal glomerulosa cells.
@en
P2093
P356
P1433
P1476
Phospholipase D activity under ...... in adrenal glomerulosa cells.
@en
P2093
Michael A Frohman
Wendy B Bollag
William E Rainey
Ying-Ying Tsai
Zhi-qiang Pan
P304
P356
10.1210/EN.2014-1159
P407
P577
2014-06-23T00:00:00Z